Gene Cell Therapy
As one of the first Gene Cell therapy focused CDMOs in China, we have a robust portfolio of Stem cell and immune cell therapy production solutions. Whether you’re an international biotech looking to enter the Chinese cell therapy market or a local company in China looking to scale production, BioMetas has a variety of solutions that can work for you.
BioMetas offers a number of solutions at different stages of the GCT pipeline development process, whether you are looking to produce small batch cell therapies for IIT studies or IND, mid-sized batches for Clinical, or large commercial projects, BioMetas is a one-stop shop for all your needs.
Our State of the Art 4,600 Sqm Stem cell & Immune cell therapy focused CDMO production facility lies in the heart of Shanghai’s Jin Qiao district. Our connected facility was built in collaboration with Haier Biomedical to leverage IOT for unique data insights to optimize and ensure world-class quality.
As one of the first Gene Cell therapy focused CDMOs in China, we have a robust portfolio of Stem cell and immune cell therapy production solutions. Whether you’re an international biotech looking to enter the Chinese cell therapy market or a local company in China looking to scale production, BioMetas has a variety of solutions that can work for you.
BioMetas offers a number of solutions at different stages of the GCT pipeline development process, whether you are looking to produce small batch cell therapies for IIT studies or IND, mid-sized batches for Clinical, or large commercial projects, BioMetas is a one-stop shop for all your needs.
Our State of the Art 4,600 Sqm Stem cell & Immune cell therapy focused CDMO production facility lies in the heart of Shanghai’s Jin Qiao district. Our connected facility was built in collaboration with Haier Biomedical to leverage IOT for unique data insights to optimize and ensure world-class quality.
Leveraging IOT to Optimize
Our partnership with Haier Medical to build a connected factory provides us with unique insights on how to optimize production runs, maintain higher facility uptime, and provide better quality assurance for products. We continue to build-out and update or production plants with innovative technologies as we strive to push the envelop on providing clients with more transparency and higher quality products.
